Eyeworld

EW FEATURE 79 February 2011 February 2011 GLAUCOMA Indicated for use in patients with medically uncontrollable glaucoma and poor surgical prognosis; this can include: neovascular glaucoma, aphakic/pseudophakic glaucoma, failed conventional surgery, congenital glaucoma, and secondary glaucoma due to uveitis, epithelial downgrowth The product is available in three models, with each featuring a larger surface area plate than competing single-quadrant devices; features a low implant profile, molded to conform to the curvature of the globe for a better fit; reduced trauma is achieved with the use of the single-quadrant insertion in comparison to multiple-quadrant sur- gery Indicated for use in patients (with prior vitrectomy) with medically uncontrollable glau- coma and poor surgical prognosis; this can include: neovascular glaucoma, aphakic/pseudophakic glaucoma, failed conventional surgery, congenital glaucoma, and secondary glaucoma due to uveitis, epithelial downgrowth The product is designed for placement during or following a pars plana vitrectomy; the 90-degree elbow is specifically designed for insertion into the posterior chamber through a 20-gauge pars plana sclerostomy incision Intended to reduce IOP in glaucoma patients where medical and conventional surgical treatments have failed The EX-PRESS Glaucoma Filtration Device implanted under the sclera flap has similar IOP-lowering efficacy as compared to trabeculectomy; post-op aqueous flow is con- trolled by its unique flow-modulating design and the sclera flap; less hypotony and choroidal effusion is experienced with the EX-PRESS Glaucoma Filtration Device com- pared to trabeculectomy; does not require a sclerectomy or peripheral iridectomy Indicated for use as an aqueous drainage/shunt device to be implanted to reduce IOP in the anterior chamber of the eye; also indicated for use in patients with secondary glaucoma and for those with primary glaucoma whose filtration surgery failed Low profile flexible silicone implant (0.9 mm) designed for single quadrant insertion while providing a large surface area (365 mm) to facilitate better filtration for more ef- fective long-term IOP control; posterior "cut out" reduces risk of optic nerve contact; pre-attached cannula aids in checking implant flow prior to use Implants are available in two sizes and are suitable for all tube shunt indications Has a unique low profile plate; pressure ridge design is intended to promote bleb for- mation in two stages; preliminary data suggests double plate performance with sin- gle-quadrant simplicity Works well for elderly patients with reduced ciliary body function and for combined cataract and glaucoma Features preplaced suture holes that ensure correct positioning on the globe Indicated for use in cases of very severe glaucoma; can be used on patients with es- pecially vigorous fibrous tissue response, younger patients with good ciliary body function, and glaucoma associated with uveitis and retinal detachment The twin plate design provides twice the drainage area without interfering with extra- ocular muscle movement; the surgeon has the choice of left or right eye configura- tions; the two implant plates allow for two independent bleb systems in adjacent quadrants; as a result, the blebs are connected by a tube allowing the free flow of aqueous between the two separate bleb systems Indicated for the reduction of intraocular pressure Mini version of the Single Plate Molteno Implant has a diameter of 8 mm Indicated for treatment of open-angle glaucoma; prevents fibrosis of deep scleral space for 6-9 months Promotes formation of shallow diffuse bleb; IOP reduction similar to trabeculectomy with appropriate dissection; when using a non-penetrating deep sclerectomy proce- dure, results have shown that intraocular pressure is lowered and complications often associated with penetrating procedures and the need for medications are reduced Indications Additional features 58-81 Feature_EW February 2011-DL2_Layout 1 2/4/11 2:32 PM Page 79

• Cover